137
Views
6
CrossRef citations to date
0
Altmetric
Perspectives

Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pieter Dylst, Arnold Vulto & Steven Simoens. (2015) Societal value of generic medicines beyond cost-saving through reduced prices. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 701-711.
Read now

Articles from other publishers (5)

Mercedes Rozano. 2019. Healthcare Policy and Reform. Healthcare Policy and Reform 1236 1261 .
Evelien Moorkens, Arnold G. Vulto, Isabelle Huys, Pieter Dylst, Brian Godman, Simon Keuerleber, Barbara Claus, Maria Dimitrova, Guenka Petrova, Ljiljana Sović-Brkičić, Juraj Slabý, Robin Šebesta, Ott Laius, Allan Karr, Morgane Beck, Jaana E. Martikainen, Gisbert W. Selke, Susan Spillane, Laura McCullagh, Gianluca Trifirò, Patricia Vella Bonanno, Asbjørn Mack, Antra Fogele, Anita Viksna, Magdalena Władysiuk, Helder Mota-Filipe, Dmitry Meshkov, Marija Kalaba, Simona Mencej Bedrač, Jurij Fürst, Corrine Zara, Peter Skiöld, Einar Magnússon & Steven Simoens. (2017) Policies for biosimilar uptake in Europe: An overview. PLOS ONE 12:12, pages e0190147.
Crossref
Antoni Sicras‐Mainar, Javier Rejas‐Gutiérrez, María Pérez‐Páramo & Ruth Navarro‐Artieda. (2016) Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity. Journal of Evaluation in Clinical Practice 23:2, pages 402-412.
Crossref
Mercedes Rozano. 2016. Handbook of Research on Strategic Retailing of Private Label Products in a Recovering Economy. Handbook of Research on Strategic Retailing of Private Label Products in a Recovering Economy 443 468 .
E. Picavet, D. Cassiman & S. Simoens. (2015) What is known about the cost-effectiveness of orphan drugs? Evidence from cost-utility analyses. Journal of Clinical Pharmacy and Therapeutics 40:3, pages 304-307.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.